[1] |
MAES D, SIBILA M, KUHNERT P, et al. Update on Mycoplasma hyopneumoniae infections in pigs:knowledge gaps for improved disease control[J]. Transbound Emerg Dis, 2018, 65(S1):110-124.
|
[2] |
武昱孜, 熊祺琰, 刘蓓蓓, 等. 猪肺炎支原体和猪鼻支原体双重荧光定量PCR检测方法的建立[J]. 畜牧兽医学报, 2017, 48(8):1491-1498.WU Y Z, XIONG Q Y, LIU B B, et al. Duplex real-time PCR method for detection of Mycoplasma hyopneumoniae and Mycoplasma hyorhinis[J]. Acta Veterinaria et Zootechnica Sinica, 2017, 48(8):1491-1498. (in Chinese)
|
[3] |
SIBILA M, NOFRARIAS M, LÓPEZ-SORIA S, et al. Chronological study of Mycoplasma hyopneumoniae infection, seroconversion and associated lung lesions in vaccinated and non-vaccinated pigs[J]. Vet Microbiol, 2007, 122(1-2):97-107.
|
[4] |
MAES D, SEGALES J, MEYNS T, et al. Control of Mycoplasma hyopneumoniae infections in pigs[J]. Vet Microbiol, 2008, 126(4):297-309.
|
[5] |
SIBILA M, PIETERS M, MOLITOR T, et al. Current perspectives on the diagnosis and epidemiology of Mycoplasma hyopneumoniae infection[J]. Vet J, 2009, 181(3):221-231.
|
[6] |
THACKER E L. Diagnosis of Mycoplasma hyopneumoniae[J]. Anim Health Res Rev, 2004, 5(2):317-320.
|
[7] |
WANG H Y, FENG Z X, WU Y Z, et al. The effects of Mycoplasma hyopneumoniae on porcine circovirus type 2 replication in vitro PK-15 cells[J]. Res Vet Sci, 2016, 105:56-61.
|
[8] |
FENG Z X, SHAO G Q, LIU M J, et al. Immune responses to the attenuated Mycoplasma hyopneumoniae 168 strain vaccine by intrapulmonic immunization in piglets[J]. Agric Sci China, 2010, 9(3):423-431.
|
[9] |
FISCH A, MARCHIORO S B, GOMES C K, et al. Commercial bacterins did not induce detectable levels of antibodies in mice against Mycoplasma hyopneumoniae antigens strongly recognized by swine immune system[J]. Trials Vaccinol, 2016, 5:32-37.
|
[10] |
THACKER E L, THACKER B J, KUHN M, et al. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs[J]. Am J Vet Res, 2000, 61(11):1384-1389.
|
[11] |
HAESEBROUCK F, PASMANS F, CHIERS K, et al. Efficacy of vaccines against bacterial diseases in swine:what can we expect?[J]. Vet Microbiol, 2004, 100(3-4):255-268.
|
[12] |
MINION F C, ADAMS C, TSUNGDA H. R1 region of P97 mediates adherence of Mycoplasma hyopneumoniae to swine cilia[J]. Infect Immun, 2000, 68(5):3056-3060.
|
[13] |
BARATE A K, CHO Y, TRUONG Q L, et al. Immunogenicity of IMS 1113 plus soluble subunit and chimeric proteins containing Mycoplasma hyopneumoniae P97 C-terminal repeat regions[J]. FEMS Microbiol Lett, 2014, 352(2):213-220.
|
[14] |
SIMIONATTO S, MARCHIORO S B, MAES D, et al. Mycoplasma hyopneumoniae:from disease to vaccine development[J]. Vet Microbiol, 2013, 165(3-4):234-242.
|
[15] |
MARCHIORO S B, FISCH A, GOMES C K, et al. Local and systemic immune responses induced by a recombinant chimeric protein containing Mycoplasma hyopneumoniae antigens fused to the B subunit of Escherichia coli heat-labile enterotoxin LTB[J]. Vet Microbiol, 2014, 173(1-2):166-171.
|
[16] |
JENKINS C, WILTON J L, MINION F C, et al. Two domains within the Mycoplasma hyopneumoniae cilium adhesin bind heparin[J]. Infect Immun, 2006, 74(1):481-487.
|
[17] |
HSU T, ARTIUSHIN S, MINION F C. Cloning and functional analysis of the P97 swine cilium adhesin gene of Mycoplasma hyopneumoniae[J]. J Bacteriol, 1997, 179(4):1317-1323.
|
[18] |
CONCEICAO F R, MOREIRA N, DELLAGOSTIN O A. A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice[J]. Vaccine, 2006, 24(29-30):5734-5743.
|
[19] |
FENG Z X, SHAO G Q, LIU M J, et al. Development and validation of a SIgA-ELISA for the detection of Mycoplasma hyopneumoniae infection[J]. Vet Microbiol, 2010, 143(2-4):410-416.
|
[20] |
FENG Z X, BAI Y, YAO J T, et al. Use of serological and mucosal immune responses to Mycoplasma hyopneumoniae antigens P97R1, P46 and P36 in the diagnosis of infection[J]. Vet J, 2014, 202(1):128-133.
|
[21] |
沈青春, 王芳, 韩明远, 等. 猪肺炎支原体P46基因的原核表达与间接ELISA方法的建立[J]. 畜牧兽医学报, 2012, 43(3):431-437.SHEN Q C, WANG F, HAN M Y, et al. Expression of P46 protein of Mycoplasma hyopneumoniae in Escherichia coli and used for indirect ELISA[J]. Acta Veterinaria et Zootechnica Sinica, 2012, 43(3):431-437. (in Chinese)
|
[22] |
肖增鸿, 黄昭亮, 林月霞, 等. 腹水型单克隆抗体纯化方法的研究[J]. 中国医药生物技术, 2013, 8(6):425-428.XIAO Z H, HUANG Z L, LIN Y X, et al. Study on purification methods of monoclonal antibody from mouse ascites fluid[J]. Chinese Medicinal Biotechnology, 2013, 8(6):425-428. (in Chinese)
|
[23] |
贺佳慧, 白满元, 郭慧琛, 等. 兔抗O型口蹄疫VLPs酶标抗体的制备及初步应用[J]. 动物医学进展, 2019, 40(1):20-24.HE J H, BAI M Y, GUO H C, et al. Preparation of rabbit anti-type O foot-and-mouth disease virus VLPs IgG-HRP[J]. Progress in Veterinary Medicine, 2019, 40(1):20-24. (in Chinese)
|
[24] |
张悦. 猪肺炎支原体P65蛋白的克隆表达、单克隆抗体制备及阻断ELISA抗体检测方法建立[D]. 南京:南京农业大学, 2013.ZHANG Y. Cloning and expression of P65 gene from Mycoplasma hyopneumoniae、preparation of the monoclonal antibody against P65 protein and establishment of blocking ELISA for antibody to Mycoplasma hyopneumoniae[D]. Nanjing:Nanjing Agricultural University, 2013. (in Chinese)
|
[25] |
OKAMBA F R, ARELLA M, MUSIC N, et al. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine[J]. Vaccine, 2010, 28(30):4802-4809.
|
[26] |
LEE S H, LEE S, CHAE C, et al. A recombinant chimera comprising the R1 and R2 repeat regions of M. hyopneumoniae P97 and the N-terminal region of A. pleuropneumoniae ApxIII elicits immune responses[J]. BMC Vet Res, 2014, 10(1):43.
|
[27] |
SHIMOJI Y, OISHI E, MUNETA Y, et al. Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine[J]. Vaccine, 2003, 21(5-6):532-537.
|
[28] |
OGAWA Y, OISHI E, MUNETA Y, et al. Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector[J]. Vaccine, 2009, 27(33):4543-4550.
|